Algunos estudios sugieren que niveles altos de TMAO en sangre podran aumentar el riesgo de problemas cardiovasculares
Your GP can determine the specific cause through clinical assessment and targeted investigations
Individual results vary based on starting weight, dose, diet, activity level, and other factors
INDICATIONS AND USAGE For the acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency
NICE (the National Institute for Health and Care Excellence) has not issued any guidance on retatrutide, as technology appraisals are only initiated once a medicine has received or is close to receiving regulatory approval
Any consideration of combination therapy would be off-label, requiring explicit informed consent, enhanced monitoring, and careful documentation